Characterization of tumor response with lenvatinib plus pembrolizumab (LEN + Pembro) in the ENGOT-en9/LEAP-001 study Meeting Abstract
| Authors: | Danska-Bidzinska, A.; Makker, V.; Salutari, V.; Ayhan, A.; Romero, I.; Levy, T.; McCormack, M.; Baurain, J. F.; Mach, P.; Cadoo, K. A.; Mackay, H.; Friedlander, M. L.; Santin, A. D.; Slomovitz, B. M.; Miller, D. S.; McKenzie, J.; Yao, L.; Khemka, V.; Nogueira-Rodrigues, A.; Marth, C. |
| Abstract Title: | Characterization of tumor response with lenvatinib plus pembrolizumab (LEN + Pembro) in the ENGOT-en9/LEAP-001 study |
| Meeting Title: | ESMO Congress 2024 |
| Journal Title: | Annals of Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sep 13-17 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-09-01 |
| Start Page: | S561 |
| Language: | English |
| ACCESSION: | WOS:001326612901044 |
| DOI: | 10.1016/j.annonc.2024.08.799 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 737P -- Source: Wos |
